Properties
| Product Name: | SM-GLP1 |
|---|---|
| Capacity / Format: | 5mg, 10mg, 13mg Lyophilized Powder |
| Specification / Material: | Acylated GLP-1 Receptor Agonist Analogue |
Product Details
Description:
SM-GLP1 is a long-acting synthetic peptide agonist of the human Glucagon-Like Peptide-1 (GLP-1) receptor. Engineered with a C18 fatty diacid chain and AIB substitution at position 8, SM-GLP1 exhibits high albumin binding and prolonged receptor signaling, serving as an ideal model for glucose-dependent insulin secretion and appetite suppression research.
Wholesale Information
- Please contact us directly for wholesale orders larger than the quantities listed online.
Intended Use
- This product is sold strictly for in vitro laboratory research and development purposes ONLY.
- It is intended to be used as a high-purity research chemical or laboratory accessory in a controlled environment.
- This is a lab supply product and is NOT intended for human or veterinary use, or for any application outside of a research setting.
Handling and Storage
- Storage: Store in a clean, dry location at controlled temperature as specified on label (-20°C for lyophilized peptides, 2-8°C for liquid solutions).
- Usage: Maintain strict aseptic technique during handling to prevent microbial contamination and preserve sample integrity.
Quality Assurance
- Every batch is independently verified via HPLC, Mass Spectrometry, or analytical testing to confirm purity, identity, and reported specifications.
Disclaimer
Purchase of this product signifies an agreement that it will be used solely for legitimate laboratory research purposes by qualified individuals trained in laboratory procedures and safety. The buyer assumes all responsibility for the proper handling, storage, use, and disposal of this product. The seller makes no claims regarding the suitability of this product for any particular research application. All product descriptions and details found on this website are intended for educational, research and informational purposes only.











































